FTC sees 'turning point' in battle against pay-for-delay
The U.S. government's decade-long fight to limit drugmakers' ability to keep generic medicines off the market may reach "a turning point" soon, Federal Trade Commission Chairman Jonathan Leibowitz told Bloomberg. Report
Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product
Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.